Respuesta a las preguntas sobre el tratamiento y la investigación de la EM progresiva: ¡Ver en español!

Watch the International Progressive MS Alliance webcast

La FDA respalda la investigación adicional sobre la “cadena liviana de neurofilamentos”

The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the biomarker ‘neurofilament light chain’

El profesor Alan Thompson gana el prestigioso premio Charcot de EM

Professor Thompson wins the 2021 lifetime achievement award for outstanding research into the understanding and treatment of MS

La Alianza financia 19 becas al desafío de la investigación en la búsqueda de respuestas para la progresión

In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in progressive MS

Recibe información sobre los últimos avances en los tratamientos para EM progresiva

A first-of-its-kind global research network funded by the International Progressive MS Alliance aims to develop new, effective treatments for progressive MS.

Investigación sobre cómo combatir la inflamación del cerebro en la esclerosis múltiple gracias a la información del intestino

This paper was first published in Nature January 2021

EM progresiva y novedosos tratamientos en rápido desarrollo

Global webcast on 4 March

‎¿Cómo agilizamos la aplicación de tratamientos decisivos para la vida de personas con EM progresiva?

Join the discussion about research breakthroughs that could accelerate new treatments for people with progressive MS

Un biomarcador potencial para la EM progresiva

The use of neurofilament light chain (NfL) as a biomarker could revolutionise clinical trials in progressive MS.

Global webcast on fatigue in progressive MS

Register below for the global webcast on fatigue research and treatment

Mitocondrias con gran energía: una posible vía para tratar la EM progresiva

New research funded by the International Progressive MS Alliance looks at ways that nerve fibres protect themselves from damage.

Answering today’s big questions in progressive MS

Watch the International Progressive MS Alliance webcast here

Discovering life-changing treatments for progressive MS

An International Progressive MS Alliance global webcast

Let’s talk about symptoms and well-being in progressive MS

Register for the Progressive MS Alliance's Facebook Live event on symptom management and well-being in progressive MS

Join the discussion on symptom management & well-being in progressive MS

Register for the Progressive MS Alliance's Facebook Live event

Challenges in Progressive MS Awards: taking risks to reap rewards

Progressive MS Awards

La primera organización de EM en América Latina se une a la Alianza Internacional de la EM Progresiva

The International Progressive MS Alliance is growing!

Global webcast on solving progressive MS: progress achieved and hope for the future

Results released from first multi-drug clinical trial in MS

The results of the MS-SMART trial, an innovative trial testing multiple drugs at the same time, have ruled out three repurposed drugs for the treatment of progressive MS.

Blocking blood protein could protect nerves in MS

A treatment that blocks a type of protein that accumulates in the brain was able to reduce inflammation and damage to nerves in laboratory models of MS.

Conferencia de la Alianza de la EM Progresiva: rehabilitación y control de los síntomas 

Researchers, clinicians and people living with MS, from around the world converged on the city of Toronto in Canada for the 3rd Congress of the International Progressive MS Alliance.

Miembros de la Federación Internacional de la EM se reúnen en Londres para celebrar el 50 aniversario del movimiento global de la MSIF.

More than 100 staff, volunteers, and people with and affected by MS from 39 countries gathered in London in September for the MSIF Movement’s 50th Anniversary meetings.

La Alianza celebra una reunión fundamental en Londres

A meeting of minds took place at the recent International Progressive MS Alliance event in London

El director ejecutivo de MS Research Australia celebra el importante papel de las nuevas tecnologías para transformar la vida de las personas que tienen esclerosis múltiple

Matthew Miles, Chief Executive of MS Research Australia, shared insights on how technology is revolutionising research, treatment, diagnosis, and more